Playez you'll also get your TPM science peer review wishlist ticked off when USDA publishes Mastitis trial results in various Science mags. This Mastitis product is getting some very good traction for POH eh?
Talk of small royalties in the animal health area needs to be balanced by the magnitude of the market value for such a product ...and the fact that this Mastitis product will require by far the largest production of raw TPM material ...the volume of raw TPM required for a successful Mastitis product is bigger than any other pipeline POH project by many times . Thus Mastitis could be worth more to POH than OxyC- the revenue of royalties and raw TPM sales is mindboggling.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(11.1%) |
Mkt cap ! $15.86M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $505 | 101.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 11398900 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 20942354 | 24 |
View Market Depth
| Last trade - 15.50pm 14/07/2025 (20 minute delay) ? |
| AVE (ASX) Chart |